Loading: 100%
BIO RAD LABORATORIES INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 8,250 (as per Q2 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker BIOno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17150175200225250
datesClosing price (adj.)
13.10.2017223.11
11.10.2017223.77
04.10.2017225.37
27.09.2017224.44
20.09.2017233.15
13.09.2017220.47
06.09.2017216.68
30.08.2017217.84
23.08.2017217.77
16.08.2017217.03
09.08.2017218.94
02.08.2017238.60
26.07.2017238.95
19.07.2017236.00
12.07.2017226.94
05.07.2017231.69
27.06.2017218.23
20.06.2017223.67
13.06.2017222.63
06.06.2017226.35
30.05.2017221.71
23.05.2017219.36
16.05.2017223.29
09.05.2017223.12
02.05.2017220.60
25.04.2017213.15
18.04.2017205.22
11.04.2017202.71
04.04.2017201.87
28.03.2017200.13
21.03.2017195.69
14.03.2017201.93
07.03.2017195.50
28.02.2017194.64
21.02.2017192.06
14.02.2017191.75
07.02.2017189.71
31.01.2017190.08
24.01.2017185.10
17.01.2017187.96
10.01.2017188.48
03.01.2017182.91
27.12.2016183.36
19.12.2016179.90
12.12.2016179.43
05.12.2016177.80
28.11.2016171.18
21.11.2016172.83
14.11.2016169.30
07.11.2016168.58
31.10.2016158.08
24.10.2016162.89
17.10.2016161.39
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
223.11n/a
Market Capitalisation
in million USD
6,247n/a
Enterprise Value
in million USD
6,173n/a
Common Shares Outstanding
as per Apr 27, 2011
28,001,789n/a
Preferred Shares Outstanding
as per Apr 27, 2011
n/a
Average Basic Shares Outstanding
TTM
29,319,500n/a
Average Diluted Shares Outstanding
TTM
29,516,000n/a
Index Membership
n/a
Business Summary
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 2,028n/a
Gross Profit 1,116n/a
Operating Income 140n/a
EBITDA 0n/a
Net Profit 97n/a
Balance Sheet
Cash and Cash Equivalents 807n/a
Receivables 388n/a
Total Current Assets 1,817n/a
PP&E 369n/a
Total Assets 3,188n/a
Accounts Payable 110n/a
Current Debt 0n/a
Total Current Liabilities 444n/a
Long-Term Debt 732n/a
Total Liabilities 1,348n/a
Total Equity 1,840n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 55.0%n/a
Operating Margin 6.9%n/a
Net Profit Margin 4.8%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS 3.31n/a
Diluted EPS 3.29n/a
Sales per Share 69.19n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 67.34n/a
Price to Sales Ratio 3.22n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.29n/a
Other Ratios
Current Ratio 409.3%n/a
Liabilities to Equity Ratio 73.3%n/a
Debt to Assets Ratio 23.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
1,764
1,784
1,927
2,074
2,069
2,133
2,175
2,019
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-802
-784
-836
-895
-914
-954
-997
-898
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
963
1,000
1,091
1,179
1,155
1,178
1,179
1,122
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-751
-765
-807
-874
-891
-1,009
-1,029
-955
Selling, General & Administrative
-591
-601
-635
-696
-682
-798
-808
-762
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-160
-164
-172
-178
-209
-211
-220
-193
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
212
235
284
305
264
169
150
167
Non-Operating Income (Loss)
-40
-45
-64
-59
-34
-57
-18
-21
Interest Expense, net
-32
-47
-64
-53
-51
-61
-22
-22
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
-8
-5
-4
-14
-5
-9
-9
-10
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
7
4
8
22
13
13
11
Pretax Income (Loss), Adjusted
172
190
220
246
230
112
132
146
Abnormal Gains (Losses)
-29
-4
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
143
186
220
246
230
112
132
146
Income Tax (Expense) Benefit, net
-45
-37
-33
-67
-64
-35
-43
-33
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
98
149
187
179
166
78
89
113
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
98
149
187
179
166
78
89
113
Minority Interest
-9
-5
-1
0
0
0
0
0
Net Income
90
145
185
179
165
78
89
113
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
90
145
185
179
165
78
89
113
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Mar 18, 2013 n/a
calculated values,
restated on Mar 18, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 67% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
745
1,025
813
921
609
698
786
Cash & Cash Equivalents
n/a
650
907
574
463
332
413
458
Short Term Investments
n/a
95
119
239
458
277
284
329
Accounts & Notes Receivable
n/a
346
388
399
399
423
378
391
Accounts Receivable, Net
n/a
346
388
399
399
423
378
391
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
351
398
434
455
516
471
490
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
121
164
153
162
210
170
110
Prepaid Expenses
n/a
0
0
0
92
131
108
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
43
48
54
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
78
116
99
69
79
62
110
Total Current Assets
n/a
1,563
1,975
1,798
1,937
1,757
1,716
1,778
Property, Plant & Equipment, Net
n/a
302
334
350
417
414
429
438
Property, Plant & Equipment
n/a
728
812
882
1,012
1,060
1,089
1,117
Accumulated Depreciation
n/a
-426
-479
-532
-595
-645
-660
-679
Long Term Investments & Receivables
n/a
0
0
0
294
378
389
720
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
671
754
949
796
839
807
775
Intangible Assets
n/a
205
204
259
261
266
254
214
Goodwill
n/a
328
364
469
495
518
500
496
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
13
13
11
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
125
173
210
40
55
52
65
Total Noncurrent Assets
n/a
973
1,087
1,299
1,507
1,631
1,625
1,932
Total Assets
n/a
2,536
3,063
3,097
3,444
3,389
3,341
3,710
Liabilities and owners' equity
Payables & Accruals
n/a
309 308704000
320 319700000
319 319192000
331 331319000
343 342723000
317 317199000
310 309587000
Accounts Payable
n/a
93 92988000
113 113440000
129 129124000
131 130867000
149 148510000
129 128608000
0 0
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
216 215716000
206 206260000
190 190068000
200 200452000
194 194213000
189 188591000
310 309587000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
111 111268000
347 346927000
140 139923000
141 141081000
145 144749000
130 129562000
132 131764000
Deferred Revenue
n/a
0 0
21 20642000
24 24322000
26 26288000
26 26390000
27 26716000
0 0
Derivatives & Hedging
n/a
5 5132000
233 233181000
1 814000
2 1750000
2 1786000
0 265000
0 298000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
106 106136000
93 93104000
115 114787000
113 113043000
117 116573000
103 102581000
131 131466000
Total Current Liabilities
n/a
420 419972000
667 666627000
459 459115000
472 472400000
487 487472000
447 446761000
441 441351000
Long Term Debt
n/a
738 737919000
731 731100000
732 731698000
732 732414000
436 435615000
436 435710000
434 433883000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
99 98749000
125 124518000
162 161608000
223 223149000
279 278981000
274 273652000
344 343981000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
43 42894000
60 59738000
86 85522000
115 115054000
162 162110000
155 154917000
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
56 55855000
65 64780000
76 76086000
108 108095000
117 116871000
119 118735000
344 343981000
Total Noncurrent Liabilities
n/a
837 836668000
856 855618000
893 893306000
956 955563000
715 714596000
709 709362000
778 777864000
Total Liabilities
n/a
1,257 1256640000
1,522 1522245000
1,352 1352421000
1,428 1427963000
1,202 1202068000
1,156 1156123000
1,219 1219215000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
130 130447000
157 156986000
185 185334000
212 212244000
240 239986000
271 271346000
300 300408000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
996 996197000
1,182 1181687000
1,360 1359910000
1,528 1528327000
1,606 1606117000
1,695 1694962000
1,808 1808055000
Other Equity
n/a
133 133082000
198 198020000
199 198690000
275 274532000
341 340717000
219 218945000
382 382138000
Equity Before Minority Interest
n/a
1,260 1259726000
1,537 1536693000
1,744 1743934000
2,015 2015103000
2,187 2186820000
2,185 2185253000
2,491 2490601000
Minority Interest
n/a
19 19487000
4 3823000
0 445000
1 535000
0 0
0 0
0 0
Total Equity
n/a
1,279 1279213000
1,541 1540516000
1,744 1744379000
2,016 2015638000
2,187 2186820000
2,185 2185253000
2,491 2490601000
Total Liabilities & Equity
n/a
2,536 2535853000
3,063 3062761000
3,097 3096800000
3,444 3443601000
3,389 3388888000
3,341 3341376000
3,710 3709816000
Remarks restated on n/a restated on Feb 28, 2011 n/a restated on Feb 29, 2012 n/a restated on Mar 18, 2013 n/a restated on Mar 18, 2014 n/a restated on Mar 2, 2015 n/a restated on Feb 29, 2016 n/a restated on Aug 5, 2016 n/a
Cash Flow StatementCF data quality: 13% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
0
0
0
0
0
0
0
0
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
Non-Cash Items
186
323
229
263
266
169
273
186
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
0
0
0
0
0
0
0
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
186
323
229
263
266
169
273
186
Change in Fixed Assets & Intangibles
-89
-76
-91
-103
-138
-106
-136
-113
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
1
-61
-33
-125
-223
179
-10
-45
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-53
-36
-89
-159
-39
-72
-45
-4
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
-6
0
0
0
0
-4
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-141
-173
-220
-386
-400
1
-191
-167
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-12
286
217
-231
-1
-300
-2
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
13
10
13
14
11
11
15
8
Increase in Capital Stock
13
10
13
14
11
11
15
8
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
5
-2
-1
3
3
-23
-2
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
6
294
229
-214
13
-312
12
9
Net Cash Before Disc. Operations and FX
52
443
238
-337
-121
-142
94
28
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
52
443
238
-337
-121
-142
94
28
Effect of Foreign Exchange Rates
-9
2
18
5
10
10
-13
16
Net Changes in Cash
43
445
257
-332
-111
-132
82
44
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Mar 18, 2013 n/a
calculated values,
restated on Mar 18, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo